Chargement en cours...
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
Schizophrenia is a chronic psychiatric disorder which substantially impairs patients’ quality of life. Despite the extensive research in this field, the pathophysiology and etiology of schizophrenia remain unknown. Different neurotransmitter systems and functional networks have been found to be affe...
Enregistré dans:
| Publié dans: | Front Pharmacol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4873505/ https://ncbi.nlm.nih.gov/pubmed/27242534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00130 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|